Keros Therapeutics KROS
NASDAQ KROS
$11.22 -0.18 (-1.58%)
As of: Oct 21, 2026 · 12:43 PM EDT

Keros Therapeutics (KROS) Current Taxes (2025)

Updated

Keros Therapeutics (KROS) reported Current Taxes of $4.15 million for Q3 2025, down 34.4% from the prior quarter.

Analysis

Keros Therapeutics (KROS) Current Taxes (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Eli Lilly 1,131.52 Bn 1,100.11 Bn 19.71 Bn -
2 Johnson & Johnson 616.33 Bn 534.86 Bn 17.26 Bn 1.05 Bn
3 AbbVie 500.08 Bn 473.19 Bn 12.70 Bn -
4 Merck 366.80 Bn 321.17 Bn 12.21 Bn 4.22 Bn
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn 2.31 Bn
6 Astrazeneca 261.59 Bn 235.28 Bn 12.86 Bn 1.47 Bn
7 Amgen 234.86 Bn 190.26 Bn 7.24 Bn -
8 Gilead Sciences 189.95 Bn 164.15 Bn 6.22 Bn -
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn 653.00 Mn
10 Keros Therapeutics 222.46 Mn -1.71 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 4.15 Mn
Jun 30, 2025 6.32 Mn
Mar 31, 2025 10.04 Mn
API Access

Keros Therapeutics Current Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-taxes&ticker=KROS&period=max&api_key=YOUR_API_KEY